SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
Please provide your email address to receive an email when new articles are posted on . An epithelium-on cross-linking procedure from Glaukos delivers oxygen to the eye during treatment. In a study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results